<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Draft Guidance for Industry on Upper Facial Lines: Developing Botulinum Toxin Drug Products; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Draft Guidance for Industry on Upper Facial Lines: Developing Botulinum Toxin Drug Products; Availability</h1>
    <p class="timestamp">Published: 2014-08-06 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Upper Facial Lines: Developing Botulinum Toxin Drug Products." The purpose of this draft guidance is to assist sponsors with their clinical trial designs using botulinum toxin drug products intended for the treatment of upper facial lines. This draft guidance clarifies FDA's thinking on endpoint development and clinical trial design considerations for botulinum toxin drug products tha...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2014-18564</p>
    <p><strong>Publication Date:</strong> 2014-08-06</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/08/06/2014-18564/draft-guidance-for-industry-on-upper-facial-lines-developing-botulinum-toxin-drug-products">https://www.federalregister.gov/documents/2014/08/06/2014-18564/draft-guidance-for-industry-on-upper-facial-lines-developing-botulinum-toxin-drug-products</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-18564</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
